ConductScience.org, home

Paper8944334

Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.

Kurbacher CM and 7 others. Breast Cancer Res Treat, 1996. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay. Papers, record 8944334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8944334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heterogeneity of in vitro chemosensitivity in perioperative breast cancer cells to mitoxantrone versus doxorubicin evaluated by a microplate ATP bioluminescence assay.
PubMed
Journal
Breast Cancer Res Treat
PubMed
Year
1996
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.75
iCite
Revised in PubMed
2026-10-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kurbacher CMC M
2Cree IAI A
3Brenne UU
4Bruckner HWH W
5Kurbacher JAJ A
6Mallmann PP
7Andreotti PEP E
8Krebs DD

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine TriphosphateMajor topic
Antibiotics, AntineoplasticMajor topic
Antineoplastic AgentsMajor topic
Breast NeoplasmsMajor topic
DoxorubicinMajor topic
Luminescent MeasurementsMajor topic
MitoxantroneMajor topic
Adult
Aged
Aged, 80 and over
Drug Screening Assays, Antitumor
Evaluation Studies as Topic
Female
Humans
Kinetics
Middle Aged
Reagent Kits, Diagnostic

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17837388Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results.JAMA1995https://conductscience.org/library/papers/7837388PubMed
21105174L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.N Engl J Med1975https://conductscience.org/library/papers/1105174PubMed
37049348Direct cloning of human breast cancer in soft agar culture.Cancer1982https://conductscience.org/library/papers/7049348PubMed
48049500The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay.Anticancer Drugs1994https://conductscience.org/library/papers/8049500PubMed
53517241A comparison of mitoxantrone and doxorubicin in breast cancer.J Clin Oncol1986https://conductscience.org/library/papers/3517241PubMed
68412158Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results.J Surg Oncol1993https://conductscience.org/library/papers/8412158PubMed
73806165A phase I-II study of intensive-dose adriamycin for advanced breast cancer.J Clin Oncol1987https://conductscience.org/library/papers/3806165PubMed
88265101Growth characteristics of nonmalignant cells in the ATP cell viability assay.Oncology1994https://conductscience.org/library/papers/8265101PubMed
93965634The human tumor clonogenic assay in human breast cancer.J Clin Oncol1985https://conductscience.org/library/papers/3965634PubMed
107208525Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay.Prog Clin Biol Res1980https://conductscience.org/library/papers/7208525PubMed
111559216Evolving concepts in the systemic adjuvant treatment of breast cancer.Cancer Res1992https://conductscience.org/library/papers/1559216PubMed
121246307Combination chemotherapy as an adjuvant treatment in operable breast cancer.N Engl J Med1976https://conductscience.org/library/papers/1246307PubMed
137762413Comparison of MTT and ATP-based assays for the measurement of viable cell number.J Biolumin Chemilumin1995https://conductscience.org/library/papers/7762413PubMed
142421936Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/2421936PubMed
156347376Mitoxantrone (novantrone): a review of experimental and early clinical studies.Cancer Treat Rev1983https://conductscience.org/library/papers/6347376PubMed
163410347Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing.Gynecol Oncol1988https://conductscience.org/library/papers/3410347PubMed
173281747The contribution of medicine to the primary treatment of breast cancer.Cancer Res1988https://conductscience.org/library/papers/3281747PubMed
187877646Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.N Engl J Med1995https://conductscience.org/library/papers/7877646PubMed
193610945Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth.In Vitro Cell Dev Biol1987https://conductscience.org/library/papers/3610945PubMed
207847834In vitro activity of titanocenedichloride versus cisplatin and doxorubicin in primary and recurrent epithelial ovarian cancer.Anticancer Res1994https://conductscience.org/library/papers/7847834PubMed

See all 31 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
35406568Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin.Cancers (Basel)2022https://conductscience.org/library/papers/35406568PubMed
35328603
Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells.
Int J Mol Sci2022https://conductscience.org/library/papers/35328603PubMed
31827757High-throughput three-dimensional spheroid tumor model using a novel stamp-like tool.J Tissue Eng2019https://conductscience.org/library/papers/31827757PubMed
20436702Individualized tumor response testing for prediction of response to Paclitaxel and Cisplatin chemotherapy in patients with advanced gastric cancer.J Korean Med Sci2010https://conductscience.org/library/papers/20436702PubMed
17211474Role of the progesterone receptor for paclitaxel resistance in primary breast cancer.Br J Cancer2007https://conductscience.org/library/papers/17211474PubMed
16026610Cancer cell adaptation to chemotherapy.BMC Cancer2005https://conductscience.org/library/papers/16026610PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8944334

GET https://conductscience.org/api/papers/v1/8944334/references?page=2